References
- Hubbell JA. (1996). Hydrogel systems for barriers and local drug delivery in the control of wound healing. J Controlled Rel 39:305–313.
- Kohane DS, Langer R. (2010). Biocompatibility and drug delivery systems. Chem Sci 1:441–446.
- Verma RK and Garg S. (2001). Current status of drug delivery technologies and future directions. Pharmaceutical Technology On-line 25:1–14.
- Alur HH, Harwick JH, Mondal P, Johnston TP. (2009). Self solidifying bioerodible barrier implant. World Intellectual Property Organization WO/2009/073658.
- Fults KA, Johnston TP. (1990). Sustained-release of urease from a poloxamer gel matrix. J Parenter Sci Technol, 44:58–65.
- United States Pharmacopoeia. (2007). Clindamycin hydrochloride monograph. USP30-NF25: 1778.
- Bamberger DM, Fields MT, Herndon BL. (1991). Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing. Antimicrob Agents Chemother, 35:2335–2339.
- Fields MT, Herndon BL, Bamberger DM. (1993). beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses. Antimicrob Agents Chemother, 37:203–206.
- United States Pharmacopoeia. (2009). General chapters <87>. Biological reactivity tests, in vitro. USP31-NF26: 102.
- Gilbert JC, Hadgraft J, Bye A, Brookes LG. (1986). Drug release from Pluronic F-127 gels. Int J Pharm 32:223–228.
- Zhang L, Parsons DL, Navarre C, Kompella UB. (2002). Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. J Control Release, 85:73–81.
- Bamberger DM, Herndon BL, Dew M, Chern RP, Mitchell H, Summers LE et al. (1997). Efficacies of ofloxacin, rifampin, and clindamycin in treatment of Staphylococcus aureus abscesses and correlation with results of an in vitro assay of intracellular bacterial killing. Antimicrob Agents Chemother, 41:1178–1181.
- Babich H, Borenfreund E. (1991). Cytotoxicity of T-2 toxin and its metabolites determined with the neutral red cell viability assay. Appl Environ Microbiol, 57:2101–2103.
- Repetto G, del Peso A, Zurita JL. (2008). Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc, 3:1125–1131.
- Li LH, Kuentzel SL, Shugars KD, Bhuyan BK. (1977). Cytotoxicity of several marketed antibiotics on mammalian cells in culture. J Antibiot, 30:506–512.
- Qian Y, Wang F, Li R, Zhang Q, Xu Q. (2010). Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide. Drug Dev Ind Pharm, 36:1340–1347.
- Ammar HO, Salama HA, Ghorab M, Mahmoud AA. (2010). Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm, 36:1330–1339.
- Ma WD, Xu H, Nie SF, Pan WS. (2008). Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property. Drug Dev Ind Pharm, 34:258–266.
- Lo JB, Appel LE, Herbig SM, McCray SB, Thombre AG. (2009). Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy. Drug Dev Ind Pharm, 35:1522–1529.
- Gonzalez YM, Ghaly ES. (2010). Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer. Drug Dev Ind Pharm 36:64–71.
- Park TH, Kim ST, Park JS, Choi HG, Kim HT, Kim CK. (2010). Effect of zinc oxide on the rheological and mucoadhesive properties of poloxamer 407-based mucoadhesive thermosensitive gel. Drug Dev Ind Pharm, 36:1436–1443.